Søren Hough: A Bispecific siRNA Design for Simultaneous Gene Silencing in Cancer
Søren Hough, Editor, Drug Modalities and TIDES Global at BioXconomy, shared a post on LinkedIn:
“Genetics is a lot more complicated than ‘turn off Gene A, get Disease B.’
Oftentimes, genetic networks look more like logic puzzles, requiring a sometimes dizzying combination of activation, silencing, modulating, and other tweaks to achieve a particular outcome.
That’s the logic researchers in Osaka, Japan, have applied to their ‘bispecific’ siRNA design: a single molecule that can shut off two genes at once. Their goal is to tackle diseases like cancer by finding consensus regions between genes with the goal of simultaneous gene silencing. Doing so could help bypass genetic redundancies that make some cancer types resistant to treatment.
Check out my story over at BioXconomy .”
Stay updated with Hemostasis Today.
-
Oct 10, 2026, 17:58Archo Farzana Batool: Exploring Medical Writing Through an Article on Iron Deficiency Anemia
-
Oct 10, 2026, 17:53Assessing Frailty in Adults With Hemophilia – JTH
-
Oct 10, 2026, 17:52Fatma Sadeghi: Reducing Maternal Health Inequalities Through Nursing Advocacy
-
Oct 10, 2026, 17:50Grzegorz Hensler: How Apheresis Transformed Blood Cell Separation and Collection
-
Oct 10, 2026, 17:47Hemant K Sharma: Japan’s Universal Artificial Blood Research – A Potential Breakthrough in Transfusion Medicine
-
Oct 10, 2026, 17:40John Strouse: Learning About Bleeding Disorders and Sickle Cell Disease at FWGBD
-
Oct 10, 2026, 17:34Mae Caime: Speaking at the Annual Women’s Retreat for the Hemophilia Community in Florida
-
Oct 10, 2026, 17:30Chokri Ben Lamine: PNH beyond the Textbook Triad
-
Oct 10, 2026, 17:29Ruah Alyamany: Thrombosis and Anticoagulation in Hematological Malignancies at SOHO KSA 2026